Literature DB >> 11274940

Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure.

M H Rubenstein1, B V Sheynberg, L C Harrell, H Schunkert, H Bazari, I F Palacios.   

Abstract

Patients with renal failure undergoing percutaneous coronary intervention (PCI) experience reduced procedural success rates and increased in-hospital and long-term follow-up major adverse cardiac events. This study was designed to determine whether the severity of preprocedural renal failure influences the outcomes of patients with renal failure undergoing PCI. We compared the immediate and long-term outcomes of 192 patients with mild renal failure (creatinine 1.6 to 2.0 mg/dl, mean 1.76) with those of 131 patients with severe renal failure (creatinine >2.0 mg/dl, mean 2.90), selected from 3,334 consecutive patients undergoing PCI between 1994 and 1997. Although the overall population with renal failure represents a high-risk group, the severe renal failure cohort had a higher incidence of hypertension, multivessel disease, prior coronary bypass surgery, vascular disease, and congestive heart failure (all p values <0.05), yet had similar angiographic characteristics. Procedural success was higher in the group with severe renal failure (93.7% vs 87.7%, p = 0.04). There were no statistically significant differences in in-hospital mortality (11.5% vs 9.9%, p = 0.7), Q-wave myocardial infarction (0.5% vs 0%, p = 0.4), emergent bypass surgery (0% vs 0%, p = 1.0), and in-hospital major adverse cardiac events (11.5% vs 9.9%, p = 0.7) between the mild and severe renal groups, respectively. Kaplan-Meier analyses showed no statistically significant difference in long-term survival (log rank test, p = 0.1) or event-free survival (log rank test, p = 0.3) between the 2 groups. Finally, creatinine was not identified as an independent predictor of in-hospital or long-term follow-up major adverse cardiac events. In our high-risk population, patients with mild renal insufficiency undergoing PCI experience major adverse outcomes in the hospital and at long-term follow-up similar to those of patients with severe renal failure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274940     DOI: 10.1016/s0002-9149(00)01526-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Effect of late revascularization of a totally occluded coronary artery after myocardial infarction on mortality rates in patients with renal impairment.

Authors:  Ramin S Hastings; Judith S Hochman; Vladimir Dzavik; Gervasio A Lamas; Sandra A Forman; Francois Schiele; Lampros K Michalis; Dimitris Nikas; Joanna Jaroch; Harmony R Reynolds
Journal:  Am J Cardiol       Date:  2012-06-22       Impact factor: 2.778

2.  Determinants of Mortality in Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention.

Authors:  Alexandros Papachristidis; Wei Yao Lim; Christos Voukalis; Salma Ayis; Christopher Laing; Roby D Rakhit
Journal:  Cardiorenal Med       Date:  2016-02-19       Impact factor: 2.041

3.  Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor.

Authors:  Vipul C Chitalia; Sowmya Shivanna; Jordi Martorell; Mercedes Balcells; Irene Bosch; Kumaran Kolandaivelu; Elazer R Edelman
Journal:  Circulation       Date:  2012-12-25       Impact factor: 29.690

4.  Prognostic factors and monomicrobial necrotizing fasciitis: gram-positive versus gram-negative pathogens.

Authors:  Ching-Yu Lee; Liang-Tseng Kuo; Kuo-Ti Peng; Wei-Hsiu Hsu; Tsan-Wen Huang; Ying-Chao Chou
Journal:  BMC Infect Dis       Date:  2011-01-05       Impact factor: 3.090

5.  Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention.

Authors:  Tanush Gupta; Neha Paul; Dhaval Kolte; Prakash Harikrishnan; Sahil Khera; Wilbert S Aronow; Marjan Mujib; Chandrasekar Palaniswamy; Sachin Sule; Diwakar Jain; Ali Ahmed; Howard A Cooper; William H Frishman; Deepak L Bhatt; Gregg C Fonarow; Julio A Panza
Journal:  J Am Heart Assoc       Date:  2015-06-16       Impact factor: 5.501

6.  Chronic kidney disease is associated with adverse outcomes among elderly patients taking clopidogrel after hospitalization for acute coronary syndrome.

Authors:  Michael J Fischer; P Michael Ho; Kelly McDermott; Elliott Lowy; Chirag R Parikh
Journal:  BMC Nephrol       Date:  2013-05-20       Impact factor: 2.388

Review 7.  An update on coronary artery disease and chronic kidney disease.

Authors:  Baris Afsar; Kultigin Turkmen; Adrian Covic; Mehmet Kanbay
Journal:  Int J Nephrol       Date:  2014-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.